Table 1.

Comparison of patient characteristics and tumor features between low and high phosphorylated AXL (pAXL) expression groups.

	Low pAXL Expression	High pAXL Expression	Total	p-Value
Sex				0.067
Female	35 (28.0%)	26 (41.3%)	61 (32.4%)
Male	90 (72.0%)	37 (58.7%)	127 (67.6%)
Age	76 (63.8, 80.3)	72.5 (57.8, 80.0)	75.0 (63.0, 80.0)	0.144
Grading				0.835
Well	4 (3.3%)	3 (4.8%)	7 (3.8%)
Moderate	30 (24.4%)	16 (25.8%)	46 (24.9%)
Low	89 (72.4%)	43 (69.4%)	132 (71.4%)
Size	4.5 (3.0, 6.5)	4.3 (2.0, 7.0)	4.5 (2.9, 7.0)	0.449
Stage				0.226
I and II	48 (38.4%)	30 (47.6%)	78 (41.5%)
III and IV	77 (61.6%)	33 (52.4%)	110 (58.5%)